Article

The Psychology of Fraud, Episode 1: Myths and Misconceptions

In this new series, experts weigh in on some of the common fallacies surrounding the nature of fraud and its perpetrators.

There are a number of misconceptions about fraud, including why people commit fraud, issues in profiling, and the “victimless” nature of it. In addition, despite the temptation to label perpetrators as “mentally ill,” this is not necessarily true. However, when investigations dismiss the greed motivation theory, important information on the real psychological causes of fraud can be revealed. Leading experts discuss these and other issues in this first episode of The Psychology of Fraud.

Mr Bigelow is president of The Bigelow Consulting Group, Inc. He also functions as the vice president—strategy, marketing, and communications for The Behavioral Forensics Group™ LLC, a consulting firm that treats fraud as a human act and explores the psychology of fraud.

Dr Morrison is a clinical assistant professor of psychiatry at Rosalind Franklin University’s Chicago School of Medicine, and past president of the Academy of Organizational and Occupational Psychiatry. He is also a member of the Group for the Advancement of Psychiatry (GAP)–Committee on Work & Organizations; Institute for Fraud Prevention (IFP); Tomkins Institute of Applied Studies of Motivation, Emotion and Cognition. He is a co-author of A.B.C.’s of Behavioral Forensics and Psychiatry of Workplace Dysfunction, and a regular contributor to the B4G™ blog, bringingfreudtofraud.com.

Dr Ramamoorti is currently an associate professor of accounting at the University of Dayton and the managing principal and CEO of The Behavioral Forensics Group™ LLC. He is also a regular contributor to the B4G™ blog, bringingfreudtofraud.com.

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
© 2024 MJH Life Sciences

All rights reserved.